Neogen profit jumps on higher revenue, tax cut
LANSING — Neogen Corp., the Lansing biotech firm, announced net income of $17.5 million or 33 cents a share in the fourth fiscal quarter ended May 31, up 41 percent …
Esperion gets positive results in another study of cholesterol-buster
ANN ARBOR — Esperion Therapeutics Inc. (Nasdaq: ESPR), the Ann Arbor company developing new treatments for high cholesterol, announced positive rsults from a Phase 2 clinical study of its drug …
Potential breakthroughs in cancer, Alzheimer’s presented in LTU’s Cisler Lecture
SOUTHFIELD – A molecular biology researcher whose discoveries are on the cusp of providing new treatments for some of humanity’s most dreaded diseases provided a fascinating lecture at Lawrence Technological …
Michigan Tech team’s idea keeps dye from dying in water
HOUGHTON — Near-infrared cyanine dyes are go-to tools for studying the inner workings of cells and investigating the biochemistry of disease, including cancer. But even though they have low toxicity …
Former Stanford Prof To Lead New MSU Biomedical Engineering Department
EAST LANSING – Christopher H. Contag will join Michigan State University as the inaugural director of the Institute for Quantitative Health Science and Engineering and chair of the new Department …